Related Experiment Videos
New polymorphisms at the insulin locus increase its usefulness as a genetic marker
Diabetes
|November 1, 1985
Summary
Researchers identified new DNA polymorphisms near the human insulin gene to improve genetic disease studies. These novel markers, including Taq I and Rsa I sites, offer greater genetic variability for family-based analyses.
Area of Science:
- Human Genetics
- Molecular Biology
- Population Genetics
Background:
- Polymorphic sites near genes are crucial for disease segregation analysis and gene mapping within families.
- The 5' flanking region (5' FP) of the human insulin gene has limited polymorphic sites, hindering detailed genetic studies.
- Previous analyses using restriction enzymes like Pvu II identified some alleles but often lacked sufficient polymorphism for informative family studies.
Purpose of the Study:
- To identify novel polymorphic DNA markers in the human insulin gene locus to enhance genetic analyses.
- To expand the available genetic markers for studying disease association with the insulin gene in diverse populations.
- To characterize new polymorphisms in Pima Indians, American Blacks, and Caucasians for improved gene mapping.
Main Methods:
- Screened over 20 kilobases (KB) of DNA at the insulin locus in Pima Indians, American Blacks, and Caucasians.
- Utilized restriction enzymes to detect polymorphisms, including previously known sites (Pst I, Hinc II) and new ones (Taq I, Rsa I, Sac I).
- Analyzed allele frequencies and assessed linkage between newly identified polymorphic sites and the 5' FP.
Main Results:
- The Pst I site polymorphism was absent in all tested populations.
- A Hinc II site (-62 BP) showed limited polymorphism in Black alleles but not in Pima Indians or Caucasians.
- New polymorphisms were discovered at Taq I (-11,000 BP) and Rsa I (-13,000 BP) sites, with varying frequencies across populations.
- A Sac I polymorphism (+2500 BP) was identified in 10% of Black alleles.
- The Hinc II, Rsa I, and Taq I sites demonstrated no apparent linkage with each other or the 5' FP.
Conclusions:
- The newly identified Taq I and Rsa I polymorphisms significantly increase the genetic variability at the human insulin locus.
- These novel markers provide valuable tools for more informative family-based genetic studies and disease association analyses.
- The findings facilitate more precise gene mapping and understanding of genetic factors influencing diseases related to the insulin gene.